FDA approves Gardasil for boys, young men

10/19/2009 | Bloomberg

The FDA has authorized Merck & Co. to begin promoting its vaccine Gardasil to protect males ages 9 to 26 against genital warts caused by human papillomavirus infections. The approval is "an important milestone" for Merck and in the treatment of HPV-related diseases, a Merck official said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA